SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-226848
Filing Date
2006-11-07
Accepted
2006-11-07 17:17:23
Documents
9
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 530485
2 FORM OF RESTRICTED STOCK UNIT AGREEMENT dex101.htm EX-10.1 19443
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9717
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9687
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3833
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3818
7 PRESS RELEASE dex991.htm EX-99.1 65658
8 GRAPHIC g64215abd001.jpg GRAPHIC 16838
9 GRAPHIC g64215abd002.jpg GRAPHIC 851
  Complete submission text file 0001193125-06-226848.txt   668699
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 061194812
SIC: 2834 Pharmaceutical Preparations